(Sharecast News) - Poolbeg Pharma revealed on Monday that chairman Cathal Friel had acquired 830,000 ordinary shares in the AIM-listed biopharmaceutical company.
Friel, who co-founded Poolbeg Pharma, purchased the shares at an average price of 11.68p each, for a total value of £96,944.
Following the transaction, Friel holds 37.21m ordinary Poolbeg shares, representing approximately 7.4% of the company's issued share capital.
As of 1620 GMT, Poolbeg shares were up 0.88% at 11.50p.
Reporting by Iain Gilbert at Sharecast.com
Top Director Buys
Poolbeg Pharma (POLB)
Director name: Friel,Cathal
Amount purchased: 830,000 @ 11.68p
Value: £96,944.00
Oryx International Growth Fund Ltd. (OIG)
Director name: Mills,Christopher
Amount purchased: 6,500 @ 1,147.30p
Value: £74,574.50
Oryx International Growth Fund Ltd. (OIG)
Director name: Mills,Christopher
Amount purchased: 4,500 @ 1,150.00p
Value: £51,750.00
Alphawave Ip Group (AWE)
Director name: Fonseca,Michelle Senecal de
Amount purchased: 25,284 @ 153.40p
Value: £38,785.66
(HWG)
Director name: Patmore,Katerina
Amount purchased: 114 @ 131.89p
Value: £150.35
(HWG)
Director name: Shillaw,Lynda
Amount purchased: 114 @ 131.89p
Value: £150.35
(HWG)
Director name: Birch,Chris
Amount purchased: 114 @ 131.89p
Value: £150.35
Xp Factory (XPF)
Director name: Harpham,Richard
Amount purchased: 939 @ 15.89p
Value: £149.21
Xp Factory (XPF)
Director name: Bird,Graham
Amount purchased: 939 @ 15.89p
Value: £149.21
Tesco (TSCO)
Director name: Murphy,Ken
Amount purchased: 49 @ 276.84p
Value: £135.65
Top Director Sells
Poolbeg Pharma (POLB)